| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 791.76M | 683.62M | 556.20M | 516.28M | 499.62M |
| Gross Profit | 228.19M | 189.94M | 176.50M | 196.84M | 201.61M |
| EBITDA | 87.20M | 94.00M | 221.53M | 248.63M | 260.43M |
| Net Income | -59.62M | 90.89M | 112.40M | 142.61M | 153.94M |
Balance Sheet | |||||
| Total Assets | 2.92B | 2.53B | 2.47B | 2.34B | 2.28B |
| Cash, Cash Equivalents and Short-Term Investments | 559.83M | 364.22M | 423.52M | 248.98M | 552.44M |
| Total Debt | 519.82M | 284.48M | 322.31M | 342.51M | 416.80M |
| Total Liabilities | 1.36B | 873.22M | 814.53M | 798.59M | 823.45M |
| Stockholders Equity | 1.56B | 1.66B | 1.65B | 1.54B | 1.46B |
Cash Flow | |||||
| Free Cash Flow | 43.08M | -7.54M | 51.27M | 110.65M | 42.98M |
| Operating Cash Flow | 230.19M | 285.34M | 268.24M | 308.42M | 195.85M |
| Investing Cash Flow | -188.85M | -296.98M | -63.95M | -352.62M | -260.09M |
| Financing Cash Flow | 133.24M | -128.65M | -30.41M | -190.49M | 258.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$3.36B | 8.76 | 15.20% | ― | 7.50% | 5.93% | |
70 Outperform | HK$600.00M | 1.86 | 7.04% | ― | 12.52% | -33.22% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | HK$206.67M | 1.93 | -8.94% | ― | 13.65% | -597.23% | |
52 Neutral | HK$158.15M | 1.35 | 2.43% | ― | -16.42% | -82.31% | |
51 Neutral | HK$241.45M | -5.83 | -3.49% | 11.00% | 15.94% | -168.02% | |
42 Neutral | HK$506.13M | -0.90 | -15.64% | 5.30% | -15.33% | -64500.00% |